The HbA1c Testing Devices Market size was estimated at USD 1.72 billion in 2023 and is expected to reach USD 3.18 billion by 2032 with a growing CAGR of 7.10% during the forecast period of 2024-2032. This report underscores the increasing prevalence and incidence of diabetes, fueling demand for HbA1c testing as a key measure for assessing long-term blood glucose control. The study discusses regulatory and reimbursement trends, looking at how government policy, insurance coverage, and healthcare funding influence market accessibility and adoption. Further, it discusses technological progress in HbA1c testing instruments, such as a transition towards point-of-care and continuous glucose monitoring for enhanced convenience to patients. The report further analyzes healthcare expenditures on diabetes control and HbA1c testing in various regions, accounting for the government, commercial, private, and out-of-pocket expenditures in dictating market expansion.
To get more information on HbA1c Testing Devices Market - Request Free Sample Report
Drivers
Rising Diabetes Prevalence and Advancements in Diagnostic Technologies
The increasing number of people suffering from diabetes is one of the major drivers for the HbA1c testing devices market, with more than 537 million adults suffering from the disease in 2021, which is estimated to increase to 783 million by 2045 (IDF). The growing diabetes burden has increased the need for HbA1c testing as a vital means to track long-term glycemic control. Technological innovations, including point-of-care (POC) devices and continuous glucose monitoring (CGM) devices, have transformed diabetes care, enabling HbA1c testing to become more convenient and streamlined. Also, rising healthcare expenditure, favorable government initiatives, and increasing health consciousness regarding early detection and disease prevention are additionally fueling market growth. The combination of AI-based diagnostic equipment and point-of-care testing solutions is also increasing patient convenience, fueling adoption levels among healthcare organizations as well as homecare environments.
Restraints
The high cost of HbA1c testing devices and consumables remains a significant barrier, particularly in low- and middle-income countries.
The cost of an HbA1c test can be as low as USD 5 to as high as USD 30 and is thus prohibitive for many patients without insurance benefits. Additionally, strict regulatory approvals, like those required by the U.S. FDA and European CE marking, tend to prolong product releases and market entry for new devices. Adherence to different international standards raises manufacturers' costs and makes cheap testing solutions scarce. Also, laboratory-based HbA1c testing is done by trained personnel and sophisticated facilities, limiting access in rural and underserved areas.
Opportunities
Expansion of Point-of-Care Testing and Telehealth Integration
The growing trend toward point-of-care (POC) testing represents a significant opportunity for growth, as these systems provide quick results and increased availability outside of clinical laboratory settings. The growing interest in POC HbA1c testing is fueled by its convenience, allowing for quicker diagnosis and the ability to change treatment more promptly. The expansion of telehealth and digital health solutions is also changing diabetes care by allowing patients to be remotely monitored and consulted. Businesses are investing in smart HbA1c analyzers with cloud connectivity, enabling real-time data sharing with healthcare professionals, and enhancing disease monitoring and patient outcomes. Collaborations between diagnostic companies and government initiatives, including the World Health Organization's Global Diabetes Compact, are also increasing market penetration, enhancing diabetes management in underserved areas. Further, growth economies offer a latent opportunity with more healthcare investments being made and local production enhancing affordability and accessibility of HbA1c testing solutions.
Challenges
A key challenge in the HbA1c testing devices market is the lack of awareness among patients and healthcare providers, particularly in developing regions.
Most people are not aware of the significance of HbA1c testing in the management of diabetes, and thus these tests are underutilized. Moreover, differences in test performance between different devices are a concern for clinicians. Although the gold standard is high-performance liquid chromatography (HPLC), other tests like immunoassays and boronate affinity chromatography can provide variable results, affecting diagnosis and treatment. Standardization attempts are being made, yet consistent accuracy on all platforms of testing is still a challenge. Additionally, supply shortages and cost barriers in remote markets impede broad adoption even further.
By Type of Device
In 2023, the point-of-care (POC) testing devices category led the HbA1c testing devices market with a high market share of 76.5%. The rising trend for rapid and more convenient test solutions has been a primary factor for the same, with POC devices facilitating real-time monitoring, instantaneous results, and increased patient compliance. The increasing incidence of diabetes, along with the demand for affordable and convenient testing options, has promoted the use of these devices in both home care and clinical environments. Further, advances in miniaturized and digital POC devices have improved accuracy and ease of use, promoting further demand. During the forecast period, the POC segment is likely to experience the fastest growth, backed by an increasing trend toward self-monitoring and decentralized healthcare. At the same time, laboratory-based testing devices are expected to expand at a profitable rate because they are more accurate and still in demand in hospitals and diagnostic labs. Although POC testing is becoming popular for its convenience, laboratory-based devices are still important for confirmatory and detailed diagnostics. The use of both types of testing ensures a holistic approach to diabetes management, addressing different patient needs in various healthcare settings.
By Technology
The immunoassays category dominated the technology segment in 2023, with a market share of 36.4%. Immunoassay-based HbA1c testing devices have emerged as the market leader because of their affordability, simplicity, and capability to give rapid and accurate results in both laboratory and point-of-care settings. The ubiquitous presence of immunoassay kits and automated analyzers has rendered this technology a first-choice option for everyday diabetes monitoring. Moreover, its adoption into current laboratory procedures and suitability with high-throughput diagnostic devices have further supported its market base. Nevertheless, high-performance liquid chromatography (HPLC) is projected to experience the most rapid expansion during the forecast period. HPLC is commonly accepted as the gold standard for HbA1c testing because it is highly precise, and accurate, and can detect hemoglobin variants that may compromise other testing approaches. With laboratories looking for more consistent and reliable testing options, demand for HPLC-based equipment is likely to increase significantly. Growing investment in sophisticated diagnostic technologies and clinical laboratory infrastructure development, especially in developing markets, will further drive the growth of the HPLC segment over the coming years.
By End-use
Hospitals & clinics led the end-use market in 2023 with a share of 41.4%, as they are still the main facilities for diabetes diagnosis, treatment, and management. The availability of experienced healthcare professionals, access to sophisticated diagnostic equipment, and the capability to perform thorough patient assessments are factors that make them market leaders. Furthermore, hospitals are usually the first point of contact for newly diagnosed diabetes patients, thus playing an important role in HbA1c testing and management of the disease over the long term. Government programs encouraging diabetes screening campaigns and hospital-based healthcare have also contributed further towards market growth in this segment. Even though hospitals dominate the market, the segment of homecare settings is expected to experience the highest rate of growth during the forecast period. The growing need for home monitoring solutions, in combination with the increased use of convenient, user-friendly portable HbA1c testing devices, is fueling this trend. Growing patient affinity for self-testing, increased consciousness regarding diabetes control, and development in digital health integration are simplifying and facilitating home-based testing. The growth of telehealth services and direct-to-consumer testing platforms is likely to further drive the adoption of HbA1c testing equipment in homecare environments, providing enhanced diabetes management and patient empowerment.
North America led the market in 2023, driven by the widespread incidence of diabetes, well-developed healthcare establishments, and extensive usage of advanced diagnostic technologies. In addition, the concentration of major market players and favorable reimbursement policies enhance market growth within this region.
Europe followed closely, with strong demand for HbA1c testing driven by growing awareness of diabetes, government healthcare programs, and a growing population of elderly citizens. These nations include Germany, the UK, and France, which are significant contributors to a highly developed diagnostic ecosystem.
The Asia-Pacific region is anticipated to experience the highest growth, fueled by the prevalence of diabetes, growing healthcare expenditures, and the expanding use of point-of-care testing solutions. Urbanization, lifestyle modifications, and government programs aimed at enhancing diabetes screening are driving market demand, especially in Japan, China, and India. The increased presence of domestic manufacturers with cheaper testing solutions also improves accessibility.
Get Customized Report as per Your Business Requirement - Enquiry Now
Bio-Rad Laboratories, Inc. – D-10 System, VARIANT II TURBO, VARIANTnxt
Abbott – Afinion 2 Analyzer, Architect c8000
F. Hoffmann-La Roche Ltd – Cobas b 101, Cobas Integra 800
Siemens Healthineers AG – DCA Vantage Analyzer, Atellica CH Analyzer
HUMAN – HumaNex A1c
Trinity Biotech – Premier Hb9210, PDQ Analyzer
Menarini Diagnostics s.r.l – HA-8180V, HA-8180T
SAKAE CO. LTD. – HbA1c Analyzer GA09
Ceragem Medisys Inc. – CM HbA1c Analyzer
SEKISUI MEDICAL CO., LTD. – SK HbA1c Analyzer
GC Medical Science Corp. – GCHbA1c Analyzer
Osang Healthcare Co., Ltd. – OHC HbA1c Analyzer
EKF Diagnostics Holdings – Quo-Lab HbA1c, Quo-Test HbA1c
Boditech Med Inc. – iChroma HbA1c
Eurolyser Diagnostica GmbH – CUBE-S HbA1c
Bayer AG – A1CNow+ System
In April 2023, FIND partnered with Abbott, i-SENS Inc., and Siemens Healthineers to enhance access to affordable point-of-care HbA1c testing in low- and middle-income countries (LMICs). This initiative, following an open call in 2021, aims to align test kit prices with target affordability benchmarks, improving diabetes diagnosis and management in resource-limited settings.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 1.72 Billion |
| Market Size by 2032 | USD 3.18 Billion |
| CAGR | CAGR of 7.10% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Type of Device [Laboratory-based Testing Devices, Point-of-care (POC) Testing Devices] • By Technology [Immunoassays, Chromatography, Enzymatic Assays, Boronate Affinity Chromatography, High-Performance Liquid Chromatography, Others] • By End-use [Hospitals & Clinics, Diagnostic Laboratories, Homecare Settings] |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Bio-Rad Laboratories, Inc., Abbott, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, HUMAN, Trinity Biotech, Menarini Diagnostics s.r.l, SAKAE CO. LTD., Ceragem Medisys Inc., SEKISUI MEDICAL CO., LTD., GC Medical Science Corp., Osang Healthcare Co., Ltd., EKF Diagnostics Holdings, Boditech Med Inc., Eurolyser Diagnostica GmbH, and Bayer AG. |
Ans: The HbA1c Testing Devices market is anticipated to grow at a CAGR of 7.10% from 2024 to 2032.
Ans: The market is expected to reach USD 3.18 billion by 2032, increasing from USD 1.72 billion in 2023.
Ans: The increasing number of people suffering from diabetes is one of the major drivers for the HbA1c testing devices market.
Ans: The high cost of HbA1c testing devices and consumables remains a significant barrier, particularly in low- and middle-income countries.
Ans: North America dominated the HbA1c Testing Devices market.
Table of content
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research & Academic Institutes Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research & Academic Institutes Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Diabetes (2023)
5.2 Regulatory and Reimbursement Trends Impacting the HbA1c Testing Market (2023-2032)
5.3 Technological Trends in HbA1c Testing Devices
5.4 Healthcare Spending on Diabetes Management and HbA1c Testing (2023), by Region (Government, Commercial, Private, Out-of-Pocket)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and Promotional Activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. HbA1c Testing Devices Market Segmentation, by Type of Device
7.1 Chapter Overview
7.2 Laboratory-based Testing Devices
7.2.1 Laboratory-based Testing Devices Market Trends Analysis (2020-2032)
7.2.2 Laboratory-based Testing Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Point-of-care (POC) Testing Devices
7.3.1 Point-of-care (POC) Testing Devices Market Trends Analysis (2020-2032)
7.3.2 Point-of-care (POC) Testing Devices Market Size Estimates and Forecasts to 2032 (USD Billion)
8. HbA1c Testing Devices Market Segmentation, by Technology
8.1 Chapter Overview
8.2 Immunoassays
8.2.1 Immunoassays Market Trends Analysis (2020-2032)
8.2.2 Immunoassays Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Chromatography
8.3.1 Chromatography Market Trends Analysis (2020-2032)
8.3.2 Chromatography Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 Enzymatic Assays
8.4.1 Enzymatic Assays Market Trends Analysis (2020-2032)
8.4.2 Enzymatic Assays Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Boronate Affinity Chromatography
8.5.1 Boronate Affinity Chromatography Market Trends Analysis (2020-2032)
8.5.2 Boronate Affinity Chromatography Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 High-Performance Liquid Chromatography
8.6.1 High-Performance Liquid Chromatography Market Trends Analysis (2020-2032)
8.6.2 High-Performance Liquid Chromatography Market Size Estimates and Forecasts to 2032 (USD Billion)
8.7 Others
8.7.1 Others Market Trends Analysis (2020-2032)
8.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. HbA1c Testing Devices Market Segmentation, by End-use
9.1 Chapter Overview
9.2 Hospitals & Clinics
9.2.1 Hospitals & Clinics Market Trends Analysis (2020-2032)
9.2.2 Hospitals & Clinics Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Diagnostic Laboratories
9.3.1 Diagnostic Laboratories Market Trends Analysis (2020-2032)
9.3.2 Diagnostic Laboratories Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Homecare Settings
9.4.1 Homecare Settings Market Trends Analysis (2020-2032)
9.4.2 Homecare Settings Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America HbA1c Testing Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.2.3 North America HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.2.4 North America HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.2.5 North America HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.2.6 USA
10.2.6.1 USA HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.2.6.2 USA HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.2.6.3 USA HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.2.7 Canada
10.2.7.1 Canada HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.2.7.2 Canada HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.2.7.3 Canada HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.2.8 Mexico
10.2.8.1 Mexico HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.2.8.2 Mexico HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.2.8.3 Mexico HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe HbA1c Testing Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.1.3 Eastern Europe HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.1.4 Eastern Europe HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.5 Eastern Europe HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.1.6 Poland
10.3.1.6.1 Poland HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.1.6.2 Poland HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.6.3 Poland HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.1.7 Romania
10.3.1.7.1 Romania HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.1.7.2 Romania HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.7.3 Romania HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.1.8 Hungary
10.3.1.8.1 Hungary HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.1.8.2 Hungary HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.8.3 Hungary HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.1.9 turkey
10.3.1.9.1 Turkey HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.1.9.2 Turkey HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.9.3 Turkey HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.1.10.2 Rest of Eastern Europe HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.1.10.3 Rest of Eastern Europe HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe HbA1c Testing Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.3.2.3 Western Europe HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.2.4 Western Europe HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.5 Western Europe HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.2.6 Germany
10.3.2.6.1 Germany HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.2.6.2 Germany HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.6.3 Germany HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.2.7 France
10.3.2.7.1 France HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.2.7.2 France HbA1c Testing Devices Market Estimates and Forecasts, by Technology(2020-2032) (USD Billion)
10.3.2.7.3 France HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.2.8 UK
10.3.2.8.1 UK HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.2.8.2 UK HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.8.3 UK HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.2.9 Italy
10.3.2.9.1 Italy HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.2.9.2 Italy HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.9.3 Italy HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.2.10 Spain
10.3.2.10.1 Spain HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.2.10.2 Spain HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.10.3 Spain HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.2.11.2 Netherlands HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.11.3 Netherlands HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.2.12.2 Switzerland HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.12.3 Switzerland HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.2.13 Austria
10.3.2.13.1 Austria HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.2.13.2 Austria HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.13.3 Austria HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.3.2.14.2 Rest of Western Europe HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.3.2.14.3 Rest of Western Europe HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific HbA1c Testing Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.4.3 Asia Pacific HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.4.4 Asia Pacific HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.5 Asia Pacific HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.4.6 China
10.4.6.1 China HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.4.6.2 China HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.6.3 China HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.4.7 India
10.4.7.1 India HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.4.7.2 India HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.7.3 India HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.4.8 Japan
10.4.8.1 Japan HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.4.8.2 Japan HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.8.3 Japan HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.4.9 South Korea
10.4.9.1 South Korea HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.4.9.2 South Korea HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.9.3 South Korea HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.4.10 Vietnam
10.4.10.1 Vietnam HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.4.10.2 Vietnam HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.10.3 Vietnam HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.4.11 Singapore
10.4.11.1 Singapore HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.4.11.2 Singapore HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.11.3 Singapore HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.4.12 Australia
10.4.12.1 Australia HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.4.12.2 Australia HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.12.3 Australia HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.4.13.2 Rest of Asia Pacific HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.4.13.3 Rest of Asia Pacific HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East HbA1c Testing Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.1.3 Middle East HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.5.1.4 Middle East HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.5 Middle East HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.5.1.6 UAE
10.5.1.6.1 UAE HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.5.1.6.2 UAE HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.6.3 UAE HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.5.1.7 Egypt
10.5.1.7.1 Egypt HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.5.1.7.2 Egypt HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.7.3 Egypt HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.5.1.8.2 Saudi Arabia HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.8.3 Saudi Arabia HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.5.1.9 Qatar
10.5.1.9.1 Qatar HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.5.1.9.2 Qatar HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.9.3 Qatar HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.5.1.10.2 Rest of Middle East HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.1.10.3 Rest of Middle East HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa HbA1c Testing Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.5.2.3 Africa HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.5.2.4 Africa HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.2.5 Africa HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.5.2.6 South Africa
10.5.2.6.1 South Africa HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.5.2.6.2 South Africa HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.2.6.3 South Africa HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.5.2.7.2 Nigeria HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.2.7.3 Nigeria HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.5.2.8.2 Rest of Africa HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.5.2.8.3 Rest of Africa HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America HbA1c Testing Devices Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
10.6.3 Latin America HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.6.4 Latin America HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6.5 Latin America HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.6.6 Brazil
10.6.6.1 Brazil HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.6.6.2 Brazil HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6.6.3 Brazil HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.6.7 Argentina
10.6.7.1 Argentina HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.6.7.2 Argentina HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6.7.3 Argentina HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.6.8 Colombia
10.6.8.1 Colombia HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.6.8.2 Colombia HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6.8.3 Colombia HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America HbA1c Testing Devices Market Estimates and Forecasts, by Type of Device (2020-2032) (USD Billion)
10.6.9.2 Rest of Latin America HbA1c Testing Devices Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
10.6.9.3 Rest of Latin America HbA1c Testing Devices Market Estimates and Forecasts, by End-use (2020-2032) (USD Billion)
11. Company Profiles
11.1 Bio-Rad Laboratories, Inc.
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Product / Services Offered
11.1.4 SWOT Analysis
11.2 Abbott
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Product / Services Offered
11.2.4 SWOT Analysis
11.3 F. Hoffmann-La Roche Ltd
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Product / Services Offered
11.3.4 SWOT Analysis
11.4 Siemens Healthineers AG
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Product / Services Offered
11.4.4 SWOT Analysis
11.5 Trinity Biotech
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Product / Services Offered
11.5.4 SWOT Analysis
11.6 Menarini Diagnostics s.r.l
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Product / Services Offered
11.6.4 SWOT Analysis
11.7 SAKAE CO. LTD.
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Product / Services Offered
11.7.4 SWOT Analysis
11.8 SEKISUI MEDICAL CO., LTD.
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Product / Services Offered
11.8.4 SWOT Analysis
11.9 Boditech Med Inc.
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Product / Services Offered
11.9.4 SWOT Analysis
11.10 Bayer AG
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Product / Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segmentation
By Type of Device
Laboratory-based Testing Devices
Point-of-care (POC) Testing Devices
By Technology
Immunoassays
Chromatography
Enzymatic Assays
Boronate Affinity Chromatography
High-Performance Liquid Chromatography
Others
By End-use
Hospitals & Clinics
Diagnostic Laboratories
Homecare Settings
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Detailed Volume Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Competitive Product Benchmarking
Geographic Analysis
Additional countries in any of the regions
Customized Data Representation
Detailed analysis and profiling of additional market players
The Telerehabilitation Market Size was valued at USD 4.7 billion in 2023 and is expected to reach USD 15.4 billion by 2032 and grow at a CAGR of 14.1%.
Pharmaceutical Sterility Testing Market was valued at USD 1.42 billion in 2023 and is expected to reach USD 3.79 billion by 2032, growing at a CAGR of 11.58%.
The Dental Biomaterials Market was valued at USD 9.41 billion in 2023 and is expected to reach USD 17.69 billion by 2032, growing at a CAGR of 7.30% from 2024-2032.
The Cardiac Implants Market size was valued at USD 38.1 billion in 2023 and is expected to reach USD 79.2 billion by 2032, growing at a CAGR of 8.5% during the forecast period from 2024 to 2032.
The Oncology Drugs Market size was USD 221.38 Billion in 2023 and is expected to Reach USD 525.08 Billion by 2031 and grow at a CAGR of 11.4% over the forecast period of 2024-2031.
The Retinal Surgery Market was valued at USD 2.46 billion in 2023 and is expected to reach USD 4.16 billion by 2032 and grow at a CAGR of 6.05% by 2024-2032
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
